This guidance describes the context of the national decommissioning of desflurane, a volatile anaesthetic agent with higher global warming potential than alternative, readily available general anaesthetic agents. It provides clarity to clinicians and systems in the NHS in England regarding the limited, permitted use of desflurane from 1 April 2024 onwards.